Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 8.19022 | 94 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 8.37943 | 95 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 8.43166 | 95 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 8.55349 | 95 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 8.70882 | 95 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 7.88179 | 94 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 7.53513 | 93 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 8.26448 | 95 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 8.49603 | 95 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 8.29363 | 94 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 7.97661 | 94 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 8.37225 | 95 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 8.3495 | 95 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 8.30313 | 95 |